Article
Despite Early Termination Due to Low Accrual, alloHCT Plus Reduced Intensity Conditioning Safe in Myeloma
Rating:
0.0
Views:
67
Likes:
1
Library:
1
When performed with a reduced-intensity conditioning regimen of bortezomib, fludarabine, and melphalan, alloHCT was safe in patients with high-risk multiple myeloma.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value